Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/116803
Title: | Resistance to antiangiogenic therapies by metabolic symbiosis in renal cell carcinoma PDX models and patients |
Author: | Jiménez Valerio, Gabriela Martínez Lozano, Mar Bassani, Nicklas Vidal-Bel, August Ochoa de Olza, Maria Suarez, Cristina García del Muro Solans, Xavier Carles, Joan Viñals Canals, Francesc Graupera i Garcia-Milà, Mariona Indraccolo, Stefano Casanovas i Casanovas, Oriol |
Keywords: | Angiogènesi Càncer de ronyó Resistència als medicaments Cèl·lules canceroses Neovascularization Renal cancer Drug resistance Cancer cells |
Issue Date: | 10-May-2016 |
Publisher: | Elsevier |
Abstract: | Antiangiogenic drugs are used clinically for treatment of renal cell carcinoma (RCC) as a standard first-line treatment. Nevertheless, these agents primarily serve to stabilize disease, and resistance eventually develops concomitant with progression. Here, we implicate metabolic symbiosis between tumor cells distal and proximal to remaining vessels as a mechanism of resistance to antiangiogenic therapies in patient-derived RCC orthoxenograft (PDX) models and in clinical samples. This metabolic patterning is regulated by the mTOR pathway, and its inhibition effectively blocks metabolic symbiosis in PDX models. Clinically, patients treated with antiangiogenics consistently present with histologic signatures of metabolic symbiosis that are exacerbated in resistant tumors. Furthermore, the mTOR pathway is also associated in clinical samples, and its inhibition eliminates symbiotic patterning in patient samples. Overall, these data support a mechanism of resistance to antiangiogenics involving metabolic compartmentalization of tumor cells that can be inhibited by mTOR-targeted drugs. |
Note: | Reproducció del document publicat a: https://doi.org/10.1016/j.celrep.2016.04.015 |
It is part of: | Cell Reports, 2016, vol. 15, num. 6, p. 1134-1143 |
URI: | http://hdl.handle.net/2445/116803 |
Related resource: | https://doi.org/10.1016/j.celrep.2016.04.015 |
ISSN: | 2211-1247 |
Appears in Collections: | Articles publicats en revistes (Ciències Fisiològiques) Articles publicats en revistes (Patologia i Terapèutica Experimental) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) Publicacions de projectes de recerca finançats per la UE |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
662998.pdf | 6.3 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License